| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | MG4M3QB242 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Epidermal growth factor receptor erbB1 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 339186-68-4 |
| ChEMBL | CHEMBL2108038 |
| FDA SRS | MG4M3QB242 |
CONTENTS